Daito Pharmaceutical Co.,Ltd.
4577
Rank in Stocks
#15975
Daito Pharmaceutical Co.,Ltd. is a global entity primarily involved in the... Daito Pharmaceutical Co.,Ltd. is a global entity primarily involved in the creation and sale of a diverse range of pharmaceutical products. Their offerings span active pharmaceutical ingredients (APIs) and chemical intermediates, alongside both prescription and over-the-counter (OTC) medications, and home-delivered medicines. These products are available in various formats, including tablets, capsules, lozenges, granules, and powdered forms. Beyond its own brand, the company also provides contract manufacturing services, developing medicinal formulations for other pharmaceutical firms. Additionally, Daito Pharmaceutical markets health food products. Established in 1942, it was initially known as Daito Corporation, changing to its current name in 1992, and maintains its headquarters in Toyama, Japan.
Share Price
$8.27
Last synced: 2026-11-10
Market Cap
$233.61M
Change (1 day)
-0.15%
Change (1 year)
1.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Daito Pharmaceutical Co.,Ltd. (4577)
Category
Healthcare
Operating Margin for Daito Pharmaceutical Co.,Ltd. (4577)
Operating Margin as of November 2026 TTM: 6.76%
According to Daito Pharmaceutical Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 6.76%. At the end of 2025 the company had an operating margin of 5.18%.
Operating Margin history for Daito Pharmaceutical Co.,Ltd. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 6.76% | 30.50% |
| 2025 | 5.18% | -37.59% |
| 2024 | 8.30% | -28.14% |
| 2023 | 11.55% | -23.41% |
| 2022 | 15.08% | 24.32% |
| 2021 | 12.13% | 1.85% |
| 2020 | 11.91% | 7.78% |
| 2019 | 11.05% | 5.94% |
| 2018 | 10.43% | 3.37% |
| 2017 | 10.09% | 3.06% |
| 2016 | 9.79% | -5.23% |
| 2015 | 10.33% | 9.66% |
| 2014 | 9.42% | 1.84% |
| 2013 | 9.25% | -4.34% |
| 2012 | 9.67% | 24.45% |
| 2011 | 7.77% | 21.41% |
| 2010 | 6.40% | 2.56% |
| 2009 | 6.24% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -97.13% |
DE
|
|
| 19.68% | -97.09% |
DE
|
|
| 13.26% | -98.04% |
JP
|
|
| 17.08% | -97.47% |
CH
|
|
| 14.92% | -97.79% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Daito Pharmaceutical Co.,Ltd.'s operating margin
What is Daito Pharmaceutical Co.,Ltd.'s operating margin?
Daito Pharmaceutical Co.,Ltd.'s operating margin is 6.76%, as of Nov 2026.
What was Daito Pharmaceutical Co.,Ltd.'s operating margin in 2025?
In 2025, Daito Pharmaceutical Co.,Ltd.'s operating margin was 5.18%, compared with 8.30% in 2024.
How has Daito Pharmaceutical Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Daito Pharmaceutical Co.,Ltd.'s operating margin was highest in 2022 (15.08%) and lowest in 2025 (5.18%).
How does Daito Pharmaceutical Co.,Ltd.'s operating margin compare with similar companies?
Daito Pharmaceutical Co.,Ltd.'s operating margin (6.76%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.